Matches in SemOpenAlex for { <https://semopenalex.org/work/W2163737807> ?p ?o ?g. }
- W2163737807 abstract "Atrial fibrillation (AF) increases risk of stroke, and although this stroke risk can be ameliorated by warfarin therapy, some patients decline to adhere to warfarin therapy. A prospective clinical study could be conducted to determine whether knowledge of genetic risk for AF could increase adherence to warfarin therapy for patients who initially declined therapy. As a prelude to a potential prospective clinical study, we investigated whether the use of genetic information to increase adherence could be cost effective.Markov model assessed costs and utilities of two care strategies for AF patients who declined warfarin therapy. In the usual care strategy patients received aspirin. In the test strategy genetic risk for AF was assessed (genotype of the 4q25 locus) and some patients with a positive genetic test (≥1 risk allele) were assumed to adhere to warfarin therapy. The remaining patients received aspirin. The incremental cost-effectiveness ratio (ICER) was the ratio of the costs differential and the quality adjusted life-years (QALYs) differential for the two strategies.We found that the 4q25 genetic testing strategy, compared with the usual care strategy (aspirin therapy), would be cost-effective (ICER $ 47,148) if 2.1 % or more of the test positive patients were to adhere to warfarin therapy. The test strategy would become a cost saving strategy if 5.3 % or more of the test positive patients were to adhere to warfarin therapy. If 20 % of test positive patients were to adhere to warfarin therapy in a hypothetical cohort of 1000 patients, 7 stroke events would be prevented and 3 extra-cranial major bleeding events would be caused over 5 years, resulting in a cost savings of ~ $250,000 and a net gain of 9 QALYs.A clinical study to assess the impact of patient knowledge of genetic risk of AF on adherence to warfarin therapy would be merited because even a modest increase in patient adherence would make a genetic testing strategy cost-effective.Providing patients who declined warfarin therapy with information about their genetic risk of AF would be cost effective if this genetic risk information resulted in modest increases in adherence." @default.
- W2163737807 created "2016-06-24" @default.
- W2163737807 creator A5022440764 @default.
- W2163737807 creator A5032073217 @default.
- W2163737807 creator A5034648363 @default.
- W2163737807 creator A5042394218 @default.
- W2163737807 creator A5064567795 @default.
- W2163737807 creator A5084493158 @default.
- W2163737807 date "2015-09-29" @default.
- W2163737807 modified "2023-10-16" @default.
- W2163737807 title "Genetic risk for atrial fibrillation could motivate patient adherence to warfarin therapy: a cost effectiveness analysis" @default.
- W2163737807 cites W1577560346 @default.
- W2163737807 cites W1625841550 @default.
- W2163737807 cites W1972916440 @default.
- W2163737807 cites W1981930691 @default.
- W2163737807 cites W2001473873 @default.
- W2163737807 cites W2011939817 @default.
- W2163737807 cites W2022421312 @default.
- W2163737807 cites W2026900324 @default.
- W2163737807 cites W2028512903 @default.
- W2163737807 cites W2031949811 @default.
- W2163737807 cites W2060332838 @default.
- W2163737807 cites W2060630424 @default.
- W2163737807 cites W2066157763 @default.
- W2163737807 cites W2069451418 @default.
- W2163737807 cites W2072695285 @default.
- W2163737807 cites W2073500756 @default.
- W2163737807 cites W2095783086 @default.
- W2163737807 cites W2106143461 @default.
- W2163737807 cites W2107223823 @default.
- W2163737807 cites W2114775432 @default.
- W2163737807 cites W2117222946 @default.
- W2163737807 cites W2117582884 @default.
- W2163737807 cites W2121394112 @default.
- W2163737807 cites W2132505348 @default.
- W2163737807 cites W2144088986 @default.
- W2163737807 cites W2145657402 @default.
- W2163737807 cites W2146846821 @default.
- W2163737807 cites W2148056560 @default.
- W2163737807 cites W2153850491 @default.
- W2163737807 cites W2167924766 @default.
- W2163737807 cites W4205645630 @default.
- W2163737807 cites W4245449645 @default.
- W2163737807 cites W9086055 @default.
- W2163737807 doi "https://doi.org/10.1186/s12872-015-0100-7" @default.
- W2163737807 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4587718" @default.
- W2163737807 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26419225" @default.
- W2163737807 hasPublicationYear "2015" @default.
- W2163737807 type Work @default.
- W2163737807 sameAs 2163737807 @default.
- W2163737807 citedByCount "5" @default.
- W2163737807 countsByYear W21637378072015 @default.
- W2163737807 countsByYear W21637378072019 @default.
- W2163737807 countsByYear W21637378072020 @default.
- W2163737807 countsByYear W21637378072021 @default.
- W2163737807 crossrefType "journal-article" @default.
- W2163737807 hasAuthorship W2163737807A5022440764 @default.
- W2163737807 hasAuthorship W2163737807A5032073217 @default.
- W2163737807 hasAuthorship W2163737807A5034648363 @default.
- W2163737807 hasAuthorship W2163737807A5042394218 @default.
- W2163737807 hasAuthorship W2163737807A5064567795 @default.
- W2163737807 hasAuthorship W2163737807A5084493158 @default.
- W2163737807 hasBestOaLocation W21637378071 @default.
- W2163737807 hasConcept C126322002 @default.
- W2163737807 hasConcept C127413603 @default.
- W2163737807 hasConcept C177713679 @default.
- W2163737807 hasConcept C188816634 @default.
- W2163737807 hasConcept C2776301958 @default.
- W2163737807 hasConcept C2777628954 @default.
- W2163737807 hasConcept C2779161974 @default.
- W2163737807 hasConcept C2780645631 @default.
- W2163737807 hasConcept C71924100 @default.
- W2163737807 hasConcept C78519656 @default.
- W2163737807 hasConceptScore W2163737807C126322002 @default.
- W2163737807 hasConceptScore W2163737807C127413603 @default.
- W2163737807 hasConceptScore W2163737807C177713679 @default.
- W2163737807 hasConceptScore W2163737807C188816634 @default.
- W2163737807 hasConceptScore W2163737807C2776301958 @default.
- W2163737807 hasConceptScore W2163737807C2777628954 @default.
- W2163737807 hasConceptScore W2163737807C2779161974 @default.
- W2163737807 hasConceptScore W2163737807C2780645631 @default.
- W2163737807 hasConceptScore W2163737807C71924100 @default.
- W2163737807 hasConceptScore W2163737807C78519656 @default.
- W2163737807 hasLocation W21637378071 @default.
- W2163737807 hasLocation W21637378072 @default.
- W2163737807 hasLocation W21637378073 @default.
- W2163737807 hasLocation W21637378074 @default.
- W2163737807 hasOpenAccess W2163737807 @default.
- W2163737807 hasPrimaryLocation W21637378071 @default.
- W2163737807 hasRelatedWork W1580515681 @default.
- W2163737807 hasRelatedWork W1584071317 @default.
- W2163737807 hasRelatedWork W161844184 @default.
- W2163737807 hasRelatedWork W1959562998 @default.
- W2163737807 hasRelatedWork W1976315467 @default.
- W2163737807 hasRelatedWork W1978615979 @default.
- W2163737807 hasRelatedWork W2012572399 @default.
- W2163737807 hasRelatedWork W2021156512 @default.
- W2163737807 hasRelatedWork W2048639409 @default.
- W2163737807 hasRelatedWork W2071154986 @default.
- W2163737807 hasRelatedWork W2084936492 @default.